PENTIXAPHARM HOLDING N AG Cash Flow-to-Debt Ratio
PENTIXAPHARM HOLDING N AG cash flow-to-debt ratio. PENTIXAPHARM HOLDING N AG (PTP) has a Cash Flow-to-Debt Ratio of -0.26x as of June 2026, meaning its operating cash flow of €-2.57 Million could theoretically repay 0% of its total liabilities (€10.04 Million) in one year. See PTP FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of PENTIXAPHARM HOLDING N AG (2021–2025)
Cash flow-to-debt ratio of PENTIXAPHARM HOLDING N AG from 2021 to 2025. Historical debt coverage capacity for PENTIXAPHARM HOLDING N AG across 5 annual periods. Check cash flow reinvestment rate of PENTIXAPHARM HOLDING N AG to assess the company's total reinvestment commitment from operating cash flow.
PENTIXAPHARM HOLDING N AG Cash Flow-to-Debt Ratio by Year (2021–2025)
PENTIXAPHARM HOLDING N AG cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for PENTIXAPHARM HOLDING N AG. For the full cash flow conversion analysis, see PENTIXAPHARM HOLDING N AG (PTP) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.65x | €-17.97 Million | €6.79 Million | ▼ -999.7% |
| 2024 | -0.24x | €-4.33 Million | €17.97 Million | ▼ -382.1% |
| 2023 | 0.09x | €2.13 Million | €24.92 Million | ▲ +159.8% |
| 2022 | -0.14x | €-2.20 Million | €15.41 Million | ▲ +86.9% |
| 2021 | -1.09x | €-1.37 Million | €1.26 Million | — |